Showing results (71-80 of 149) with videos related to

Sort By:
Pageof 15
Leukemia Research|May 15, 2002
High-dose cytarabine as consolidation treatment for patients with acute myeloid leukemia with t(8;21)Salvatore Palmieri, Lucia Sebastio, Giuseppina Mele, et al.
Haematologica|March 15, 2006
The biological characteristics of CD34+ CD2+ adult acute promyelocytic leukemia and the CD34 CD2 hypergranular (M3) and microgranular (M3v) phenotypesFrancesco Albano, Anna Mestice, Alessandra Pannunzio, et al.
European Journal of Haematology|September 18, 2010
Chronic lymphocytic leukemia-associated immune thrombocytopenia treated with rituximab: a retrospective study of 21 patientsGiovanni D'Arena, Silvana Capalbo, Luca Laurenti, et al.
Leukemia Research|October 9, 2017
Low-dose lenalidomide plus cytarabine in very elderly, unfit acute myeloid leukemia patients: Final result of a phase II studyGiuseppe Visani, Felicetto Ferrara, Francesco Di Raimondo, et al.
Annals of Hematology|August 19, 2008
Sequential continuous infusion of fludarabine and cytarabine associated with liposomal daunorubicin (DaunoXome) (FLAD) in primary refractory or relapsed adult acute myeloid leukemia patientsAndrea Camera, Ciro R Rinaldi, Salvatore Palmieri, et al.
European Journal of Haematology|May 30, 2007
Rituximab for warm-type idiopathic autoimmune hemolytic anemia: a retrospective study of 11 adult patientsGiovanni D'Arena, Catello Califano, Mario Annunziata, et al.
European Journal of Haematology|June 16, 2010
Low-dose rituximab in adult patients with primary immune thrombocytopeniaFrancesco Zaja, Nicola Vianelli, Stefano Volpetti, et al.
Plos One|December 19, 2013
HDAC inhibitors repress BARD1 isoform expression in acute myeloid leukemia cells via activation of miR-19a and/or bIlaria Lepore, Carmela Dell'Aversana, Maxim Pilyugin, et al.
Cancer Medicine|March 11, 2020
Next-generation sequencing for BCR-ABL1 kinase domain mutations in adult patients with Philadelphia chromosome-positive acute lymphoblastic leukemia: A position paperSimona Soverini, Francesco Albano, Renato Bassan, et al.
Biomedicines|August 27, 2021
Hypomethylating Agents (HMAs) as Salvage Therapy in Relapsed or Refractory AML: An Italian Multicentric Retrospective StudyFederica Lessi, Marica Laurino, Cristina Papayannidis, et al.
Pageof 15